Hypophosphatasia – Diagnostics – Overview of Information and Clinical Research

Getting the right diagnosis for hypophosphatasia is the first critical step toward managing this rare bone disorder. Because symptoms can range widely—from early tooth loss to chronic pain and fractures—and can mimic more common conditions, knowing when to seek testing and what tests are involved can help patients and families find answers faster and begin appropriate treatment.

Introduction: Who Should Undergo Diagnostics

Hypophosphatasia is a rare genetic condition that affects bones and teeth, making them softer and more prone to breaking. Because it is uncommon and symptoms can vary dramatically from person to person, many people with this condition go undiagnosed for years, or are incorrectly diagnosed with other disorders. Understanding who should undergo diagnostic testing is important for catching the disease early and starting the right care.^[1]

Anyone experiencing unexplained bone pain, frequent fractures without obvious cause, premature loss of teeth—especially baby teeth that fall out with their roots still intact—or ongoing muscle weakness and fatigue should consider asking their doctor about testing for hypophosphatasia. These symptoms can appear at any age, from before birth through adulthood. In infants and young children, signs like poor feeding, failure to gain weight, delayed motor skills, soft or misshapen bones, and breathing difficulties may prompt healthcare providers to investigate further.^[2]^[3]

Adults with a history of childhood bone or dental problems, recurrent stress fractures in the feet or legs, joint swelling, or chronic body aches should also consider evaluation. Many adults report being dismissed by doctors or misdiagnosed with conditions like fibromyalgia or depression before finally receiving the correct diagnosis. If you have persistently low levels of a substance called alkaline phosphatase (a key enzyme in bone health) on routine blood work, this is an important red flag that should not be ignored, even if your doctor initially says low levels are “not a problem.”^[11]^[21]

Family history matters, too. Hypophosphatasia is inherited, meaning it runs in families. If a close relative has been diagnosed with the condition, other family members—especially those with mild or vague symptoms—may benefit from testing. Sometimes, people carry genetic changes that cause the disease but have few or no symptoms themselves. These individuals can still pass the condition on to their children.^[2]^[3]

⚠️ Important

If your doctor finds that your alkaline phosphatase levels are persistently low on blood tests, do not dismiss this finding. Many standard lab reports only flag alkaline phosphatase as abnormal when it is too high, but low levels can be just as significant and may point to hypophosphatasia. Ask your healthcare provider to review your results carefully and consider further testing if you have any related symptoms.

Diagnostic Methods

Diagnosing hypophosphatasia involves a combination of clinical evaluation, laboratory testing, imaging studies, and genetic analysis. Because the symptoms can overlap with other more common bone and metabolic disorders, a thorough and careful approach is essential to distinguish hypophosphatasia from conditions like rickets (a bone-softening disorder caused by vitamin D deficiency), osteoporosis, or other inherited bone diseases.^[3]^[6]

Clinical Evaluation

The diagnostic process usually begins with a detailed medical history and physical examination. Your doctor will ask about symptoms such as bone pain, fractures, tooth loss, muscle weakness, and developmental delays in children. They will also ask about family history, since hypophosphatasia is a genetic disorder. In children, doctors look for signs like bowed legs, abnormal skull shape, difficulty walking, or delayed motor milestones. In adults, they may notice a history of stress fractures, early tooth loss, chronic pain, or gait changes.^[9]^[11]

Seemingly unusual questions during the history-taking process can be vital clues. For example, healthcare providers experienced in diagnosing hypophosphatasia often ask whether a patient lost baby teeth early and whether those teeth came out with their roots still attached. This particular pattern of tooth loss is a hallmark sign of the condition. Similarly, a history of serious dental problems in adolescence or childhood can point toward a diagnosis that might otherwise be missed.^[11]

Laboratory Testing

Blood tests are the cornerstone of hypophosphatasia diagnosis. The most important finding is a persistently low level of alkaline phosphatase in the blood, adjusted for the patient’s age and sex. Alkaline phosphatase is an enzyme that plays a key role in building and maintaining healthy bones and teeth. When levels are too low, it signals that the body cannot properly mineralize bone tissue.^[2]^[5]^[9]

However, low alkaline phosphatase alone is not enough to confirm the diagnosis, because other factors—such as certain medications, nutritional deficiencies, or other medical conditions—can also cause low levels. For this reason, doctors typically measure additional substances in the blood and urine that accumulate when alkaline phosphatase is deficient. These include pyridoxal 5′-phosphate (PLP), a form of vitamin B6, and phosphoethanolamine (PEA), which appears in urine. Elevated levels of these substances, along with low alkaline phosphatase, strongly support the diagnosis of hypophosphatasia.^[3]^[9]^[12]

In some cases, doctors also test for inorganic pyrophosphate (PPi), another substance that builds up when alkaline phosphatase activity is low. These substrate measurements help confirm that the low enzyme activity is indeed causing problems with bone and tooth development.^[18]

Radiographic Imaging

X-rays and other imaging studies are essential tools for evaluating bone structure and identifying characteristic features of hypophosphatasia. X-rays can show signs of poor bone mineralization, which may look similar to rickets in children. Doctors may see bowed legs, widened growth plates at the wrists and ankles, or deformities in the chest and ribs. In severe cases, imaging performed before birth using ultrasound can reveal short, bowed limbs and underdeveloped ribs in the fetus.^[1]^[3]^[6]

In adults, X-rays may reveal stress fractures, especially in the feet and legs, or pseudofractures—incomplete breaks that appear as faint lines across the bone. These are particularly common in adults with hypophosphatasia and are often mistaken for other conditions. Imaging can also detect changes in bone density and help rule out other bone diseases.^[12]^[18]

More advanced imaging, such as computed tomography (CT) scans or magnetic resonance imaging (MRI), may be used in specific cases to get a clearer picture of bone structure or to evaluate complications such as craniosynostosis (premature fusion of skull bones) in infants and young children.^[1]

Genetic Testing

Genetic testing is the definitive method for confirming hypophosphatasia. The condition is caused by changes, or mutations, in the ALPL gene, which provides instructions for making the alkaline phosphatase enzyme. Identifying these mutations through genetic testing not only confirms the diagnosis but also helps predict disease severity and inheritance patterns.^[2]^[3]^[6]

More than 400 different mutations in the ALPL gene have been identified in patients with hypophosphatasia. Some mutations cause severe disease that appears before or shortly after birth, while others lead to milder forms that may not become apparent until adulthood. Genetic testing can also identify family members who carry the mutation but do not have symptoms, which is important for family planning and genetic counseling.^[3]^[6]

In 2024, an international working group established updated diagnostic criteria for hypophosphatasia in children and adolescents. According to these criteria, a diagnosis can be made when a patient has two major criteria—such as a disease-causing ALPL gene variant and elevated substrate levels like PLP or PEA, or early tooth loss—or one major criterion plus two minor criteria, which may include low bone mineral density or characteristic findings on X-rays.^[9]

Dental Examination

Because tooth problems are a hallmark of hypophosphatasia, a thorough dental examination is often part of the diagnostic workup. Dentists may observe early loss of baby teeth with roots intact, severe cavities, poorly formed teeth, or fragile tooth enamel. In a form of the condition called odontohypophosphatasia, dental problems are the only symptom, and bones are not affected. Even in these milder cases, the diagnosis is important because it can help prevent unnecessary dental treatments and inform patients and families about the genetic nature of the condition.^[1]^[14]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or evaluate existing treatments in new ways. For patients with rare diseases like hypophosphatasia, clinical trials can offer access to cutting-edge therapies and contribute to advancing medical knowledge. However, entering a clinical trial requires meeting specific criteria to ensure that participants are suitable for the study and that results are scientifically valid.^[3]

To qualify for a clinical trial related to hypophosphatasia, patients typically need to undergo the same diagnostic tests used in standard clinical practice, but often with more detailed documentation and stricter criteria. These may include comprehensive blood tests to confirm persistently low alkaline phosphatase levels and elevated substrate levels such as pyridoxal 5′-phosphate and phosphoethanolamine. Genetic testing is usually required to document the specific ALPL gene mutation, as some trials may focus on particular genetic variants or patterns of inheritance.^[3]^[9]

Imaging studies, including X-rays and sometimes more advanced scans like CT or MRI, are often required to document baseline bone structure, mineral density, and the presence of fractures or deformities. These images help researchers measure whether a treatment is working by comparing changes over time. In children, growth measurements and assessments of motor function—such as the ability to walk, stand, or reach developmental milestones—may also be part of the enrollment criteria.^[3]^[13]

Clinical trials may also have specific inclusion and exclusion criteria based on the severity of the disease. For example, some trials focus on patients with severe, life-threatening forms of hypophosphatasia that appear in infancy, while others may enroll adults with milder symptoms. Patients may be excluded if they have certain other medical conditions, are taking medications that could interfere with the study treatment, or have previously received certain therapies.^[13]^[15]

In addition to baseline diagnostic tests, participants in clinical trials are closely monitored throughout the study. This often involves repeated blood tests, imaging studies, physical exams, and quality-of-life assessments to track how well the treatment is working and to detect any side effects. These rigorous monitoring procedures help ensure patient safety and provide valuable data about the treatment’s effectiveness.^[3]^[13]

⚠️ Important

If you or your child has been diagnosed with hypophosphatasia and are interested in participating in a clinical trial, speak with your healthcare provider or contact a specialized center that treats the condition. Enrollment criteria vary by study, and not every patient will qualify, but clinical trials can offer access to new therapies and contribute to research that benefits the entire hypophosphatasia community.

It is also important to note that some diagnostic tests used in clinical trials are not yet widely available in standard clinical practice. For example, measuring inorganic pyrophosphate or conducting detailed bone imaging may require specialized equipment or expertise. Patients interested in clinical trials should work closely with their doctors and the trial’s research team to understand what tests and procedures will be involved.^[3]

Prognosis and Survival Rate

Prognosis

The outlook for patients with hypophosphatasia varies widely and depends largely on the age when symptoms first appear and the severity of the condition. Generally, the earlier symptoms develop, the more serious the disease tends to be, although this is not always the case. In the most severe form, called perinatal hypophosphatasia, infants may be stillborn or die shortly after birth due to severe bone malformations that affect breathing. Historically, survival for these infants was very poor, with only about 42% living to one year of age without treatment. However, since the approval of enzyme replacement therapy in 2015, survival rates have dramatically improved—studies have shown that 97% of treated infants survived to age one.^[13]^[15]

For children diagnosed with infantile or childhood forms of hypophosphatasia, the prognosis has also improved significantly with modern treatment. Without therapy, these children often experience ongoing bone pain, frequent fractures, delayed growth, and difficulty with physical activities. Some may develop complications such as craniosynostosis, which can lead to increased pressure in the brain, or breathing difficulties due to chest deformities. With early diagnosis and appropriate treatment, including enzyme replacement therapy, many children can achieve better bone strength, improved growth, and enhanced motor function, allowing them to participate more fully in daily activities.^[3]^[13]^[15]

Adults with hypophosphatasia, especially those with milder forms, can often live relatively normal lives, though many experience chronic pain, frequent fractures, and reduced quality of life. Symptoms may include bone and joint pain, muscle weakness, fatigue, dental problems, and difficulty with mobility. Many adults report that their symptoms have been present since childhood but were not recognized or properly diagnosed until much later. With accurate diagnosis and treatment, adults can experience significant improvements in pain, mobility, and overall well-being, allowing them to return to work and normal activities.^[11]^[18]^[21]

The prognosis is also influenced by whether patients develop complications. For example, kidney problems due to calcium buildup, inflammatory arthritis, neurological symptoms, or gastrointestinal issues can all affect long-term health. A multidisciplinary care team that includes specialists in bone disease, dentistry, physical therapy, pain management, and other areas is essential for managing these complications and optimizing outcomes.^[12]^[18]

Survival Rate

Survival rates for hypophosphatasia depend on the form of the disease. For the most severe perinatal forms, historical data showed that survival without treatment was low, with many infants dying in the first days or weeks of life due to respiratory failure caused by chest and rib deformities. In natural history studies conducted before enzyme replacement therapy was available, only about 42% of infants with perinatal or infantile hypophosphatasia survived to one year. Ventilator-free survival rates were similarly low, with many infants requiring mechanical breathing support.^[13]

Since the introduction of enzyme replacement therapy with asfotase alfa in 2015, survival rates have improved dramatically. Clinical studies have shown that 97% of infants and young children with severe hypophosphatasia who received the treatment survived to one year of age, compared to 42% of those in historical control groups. Ventilator-free survival also improved significantly, with most treated patients able to breathe on their own. Long-term follow-up studies have continued to show improved survival, better bone mineralization, enhanced respiratory function, and overall better quality of life for children treated with enzyme replacement therapy.^[13]^[15]

For milder forms of hypophosphatasia that appear in childhood or adulthood, survival is generally not threatened, but patients may face lifelong challenges related to bone pain, fractures, dental problems, and reduced physical function. With appropriate management, including supportive care, physical therapy, pain management, and in some cases enzyme replacement therapy, many patients can lead active, fulfilling lives. Ongoing research and advances in treatment continue to improve the outlook for individuals with all forms of hypophosphatasia.^[3]^[11]

#1 Clinical Trials Search in Europe